OpenVSafe by OpenVAERS
Search V-safe

95C-16367-19374

4 vaccinations 7 coded responses 27 check-ins 7 free-text entries 2 call cases
Sex
Male
Age at first dose
51-55
ZIP prefix
276 / NC
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Headache — Feeling: Good · Site: Pain
    Free text: Mild headache 3 to 4 hours after receiving the vaccine. It subsided after about 1.5 to 2 hours.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abdominal pain, Injection site reaction, Muscle tightness — Feeling: Good
    Free text: Abdominal cramps but nothing painful. Muscle tightness in R shoulder (site injection).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good
    Free text: Nasal drainage earlier today but now stuffiness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-25
    Survey response — day 7, dose 1
    MedDRA: Ageusia, Anosmia, Productive cough, Respiratory tract congestion — Feeling: Good · Muscle or body aches, Diarrhea
    Free text: Temporary loss of taste and smell, small amount of chest congestion/phlegm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-01
    Survey response — day 14, dose 1
    MedDRA: COVID-19 — Feeling: Fair
    Free text: Diagnosed with COVID on 12/29/2020.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-08
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Diarrhea
    Adult check-in
  17. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  18. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  20. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  21. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-15
    Survey response — 6 months, dose 2
    MedDRA: Office visit, Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Diagnosed with pityriasis rosea. Tryi to determine if its vaccine related or from having COVID. · Healthcare visit (other): Dermatologist
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-07-15
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-07-22
  30. 2021-07-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  31. 2021-12-31
    Dose 3 — Pfizer-BioNTech
  32. 2022-01-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  33. 2022-07-01
    Survey response — 6 months, dose 3
    MedDRA: Office visit, Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Persistent pityriasis rosea that has been ongoing now for over 15 months. · Healthcare visit (other): Dermatologist
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-07-01
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  35. 2022-07-05
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  36. 2022-08-05
    Dose 4 — Pfizer-BioNTech
  37. 2022-11-06
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32021-12-31Pfizer-BioNTech No
42022-08-05Pfizer-BioNTech No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-19

Systemic reaction (other): Mild headache 3 to 4 hours after receiving the vaccine. It subsided after about 1.5 to 2 hours.

2020-12-20

Systemic reaction (other): Abdominal cramps but nothing painful. Muscle tightness in R shoulder (site injection).

2020-12-24

Systemic reaction (other): Nasal drainage earlier today but now stuffiness

Release 1 — day 7, dose 1

2020-12-25

Systemic reaction (other): Temporary loss of taste and smell, small amount of chest congestion/phlegm

Release 1 — day 14, dose 1

2021-01-01

Symptoms: Diagnosed with COVID on 12/29/2020.

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Diagnosed with pityriasis rosea. Tryi to determine if its vaccine related or from having COVID.
Healthcare visit (other): Dermatologist

Release 12 — 6 months, dose 3

2022-07-01

Symptoms: Persistent pityriasis rosea that has been ongoing now for over 15 months.
Healthcare visit (other): Dermatologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ · ✓
SDCOVID-19 ✓ ✓ ✓
SDPityriasis rosea ✓ · ✓
SROAbdominal pain ✓ ✓ ✓
SROAgeusia ✓ ✓ ✓
SROAnosmia ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SROMuscle tightness ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SROProductive cough ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release